NeuroOne Medical Technologies Corporation (NMTC)

USD 0.74

(-6.41%)

Market Cap (In USD)

22.8 Million

Revenue (In USD)

1.95 Million

Net Income (In USD)

-11.85 Million

Avg. Volume

59.85 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.551-1.72
PE
-
EPS
-
Beta Value
0.909
ISIN
US64130M2098
CUSIP
64130M209
CIK
1500198
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. David A. Rosa M.D.
Employee Count
-
Website
https://n1mtc.com
Ipo Date
2018-03-15
Details
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.